References
- Ascione F. J., Kirking D. M., Gaither C. A., Welage L. S. Historical overview of generic medication policy. J Am Pharm Assoc 2001; 41: 567–77
- NDCHealth, PharmaTrends 2002 Year in Review, NDC Corporation, Available at http://ndchealthcom/epharma/yir/pharmatrends2002 pdf [Accessed 11 May 2005]
- Steger J. W., Wolverton S. E., Greenberg R. D., Ling M. R., Resnick S. D., James W. D. Dermatologic drug formulary: an American Academy of Dermatology white paper. J Am Acad Dermatol 1996; 34: 99–109
- Shah V. P. Progress in methodologies for evaluating bioequivalence of topical formulations. Am J Clin Dermatol 2001; 2: 275–80
- Ling M. R. The message in the medium: how and why to choose a vehicle. Fitzpatrick's J Clin Dermatol 1995; 3: 13–19
- Castanedo‐Cazares J. P., Quistian‐Galvan J., Torres‐Alvarez B., Torres‐Ruvalcaba A., Moncada B. Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug. Gac Med Mex 2001; 137: 311–14
- Cohen J. B., Bergstresser P. R. Response of Behcet's syndrome to brand‐name but not generic tetracycline. Clin Exp Dermatol 1997; 22: 159–60
- Burova K., Bansal D. Skin eruption to generic prednisolone. Br J Dermatol 1999; 141: 597–8
- Louet S. Lessons from Eprex for biogeneric firms. Nat Biotechnol 2003; 21: 956–7
- National Health Center for Health Statistics, Centers for Disease Control, Available at http://www.edc.gov/nchs/about/major/ahed/namesdes/html [Accessed 11 May 2005]
- Red Book 2004, 108th edn. 2004, Montvale, NJ. Medical Economics Co.
- CDER New and Generic Drug Approvals 1998–2004, Center for Drug Evaluation and Research, FDA. Available at: URL: http://www.fda.gov/cder/approval/ [Accessed 11 May 2005]
- How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry. Executive Summary, July 1998. Available at http://www.cbo.gov/showdoc.cfm?index = 655&sequence = 0&from = 1 [Accessed 11 May 2005]
- Skernivitz T. P. Accutane goes generic. Dermatology Times 2002
- Walgreen's Pharmacy On‐Line, Available from: URL: http://www.walgreens.com/library/finddrug/druginfosearch.jhtml [Accessed 10 May 2005]
- Smith E. S., Fleischer A. B Jr., Feldman S. R. Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990–1994. J Am Acad Dermatol 1998; 39: 43–7
- Goodwin F. K. Impact of formularies on clinical innovation. J Clin Psychiatry 2003; 64((Suppl 17))11–14
- Kirking D. M., Ascione F. J., Gaither C. A., Welage L. S. Economics and structure of the generic pharmaceutical industry. J Am Pharm Assoc 2001; 41: 578–84
- Fischer M. A., Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res 2003; 38: 1051–63